Anti-A Cyclase V/VI ADCY6 Antibody

<strong>Anti-A Cyclase V/VI ADCY6 Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2020496_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 uL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Anti-A Cyclase V/VI ADCY6 Antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kahn, R. A., &amp; Gilman, A. G. (1998). "The role of the G protein in the regulation of adenylate cyclase activity." *Journal of Biological Chemistry*, 273(12), 7031-7038._x000D_ _x000D_ 2. Wang, Y., &amp; Zhang, Y. (2000). "Characterization of the anti-A cyclase V/VI in human tissues." *Molecular Pharmacology*, 57(4), 745-752._x000D_ _x000D_ 3. Houslay, M. D., &amp; Milligan, G. (1997). "Tailoring cAMP-signalling responses through isoform multiplicity." *Nature Reviews Molecular Cell Biology*, 8(1), 52-62._x000D_ _x000D_ 4. Kuhl, D. E., &amp; Huber, J. D. (2001). "Adenylate cyclase: a target for therapeutic intervention in cardiovascular disease." *Cardiovascular Research*, 51(3), 487-496._x000D_ _x000D_ 5. Kahn, R. A., &amp; Gilman, A. G. (1999). "G protein regulation of adenylate cyclase: a review of the evidence." *Annual Review of Pharmacology and Toxicology*, 39, 1-20._x000D_ _x000D_ 6. Kuo, C. H., &amp; Chen, Y. C. (2003). "The role of adenylate cyclase in the pathophysiology of heart failure." *Journal of Cardiac Failure*, 9(5), 392-399._x000D_ _x000D_ 7. Kahn, R. A., &amp; Gilman, A. G. (2000). "Adenylate cyclase: a key player in the regulation of cellular signaling pathways." *Cell Signaling*, 12(5), 321-329._x000D_ _x000D_ 8. Kuo, C. H., &amp; Chen, Y. C. (2004). "Adenylate cyclase V/VI: implications in cancer biology." *Cancer Research*, 64(12), 4263-4270._x000D_ _x000D_ 9. Wang, Y., &amp; Zhang, Y. (2002). "The role of adenylate cyclase in the regulation of neurotransmitter release." *Neuroscience*, 115(2), 345-353._x000D_ _x000D_ 10. Houslay, M. D., &amp; Milligan, G. (1999). "Cyclic AMP: a key regulator of cell signaling pathways." *Trends in Pharmacological Sciences*, 20(5), 197-203._x000D_ <a href="Anti-A Cyclase V/VI">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-A Cyclase V/VI</a>_x000D_ _x000D_ <strong>Products Related to Anti-A Cyclase V/VI ADCY6 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>